Novavax CEO on $1.6 billion in federal funding, Covid-19 vaccine progress and more

The U.S. government has awarded Novavax $1.6 billion to support the late-stage development and scale up in manufacturing of its Covid-19 vaccine. Stanley Erck, president and CEO of Novavax, joins "Squawk Box" to discuss as well as the company's methods for developing the vaccine.
Tue, Jul 7 20207:48 AM EDT